Quantitative HER2 Profiling and Breakthroughs in Diabetes
Kilder
- Nature: Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer - Nature
- Fiercebiotech: Sana sees 14-month insulin production for transplanted islet therapy in single Type 1 diabetes patient - Fierce Biotech
- Biopharmadive: With FDA go ahead, a China biotech notches a first in cell therapy testing - BioPharma Dive
- Biospace: iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching - BioSpace
- Bioworld: First-in-class POLG activator restores mtDNA across mutations - BioWorld MedTech
- Bioworld: Aptar and Covirix Medical collaborate on inhaled antivirals - BioWorld MedTech
- wikimedia: Photo by National Heart, Lung, and Blood Institute / Wikimedia Commons / Public domain
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.